Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 18.52 USD -2.06% Market Closed
Market Cap: 534.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

CSTL Price Targets Summary
Castle Biosciences Inc

Wall Street analysts forecast CSTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSTL is 36.61 USD with a low forecast of 30.3 USD and a high forecast of 43.05 USD.

CSTL Lowest Forecast
Wall Street Target
30.3 USD
64% Upside
CSTL Average Forecast
Wall Street Target
36.61 USD
98% Upside
CSTL Highest Forecast
Wall Street Target
43.05 USD
132% Upside
Lowest
Price Target
30.3 USD
64% Upside
Average
Price Target
36.61 USD
98% Upside
Highest
Price Target
43.05 USD
132% Upside
Castle Biosciences Inc Competitors:
Price Targets
V
VOX
Voxel SA
9% Downside
603882
Guangzhou Kingmed Diagnostics Group Co Ltd
14% Upside
ADUS
Addus Homecare Corp
22% Upside
CCRN
Cross Country Healthcare Inc
29% Upside
V
VOX
Voxel SA
9% Downside
603882
Guangzhou Kingmed Diagnostics Group Co Ltd
14% Upside
ADUS
Addus Homecare Corp
22% Upside
CCRN
Cross Country Healthcare Inc
29% Upside
A
9860
Adicon Holdings Ltd
49% Upside
RDNT
RadNet Inc
28% Upside
LFST
Lifestance Health Group Inc
80% Upside
C
CCEL
Cryo-Cell International Inc
69% Upside

Revenue
Forecast

Revenue Estimate
Castle Biosciences Inc

For the last 6 years the compound annual growth rate for Castle Biosciences Inc's revenue is 56%. The projected CAGR for the next 3 years is 0%.

56%
Past Growth
0%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Castle Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Castle Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
CSTL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSTL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSTL stock valuation using valuation multiples.
Wall Street Estimates
CSTL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSTL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSTL's stock price target?
Price Target
36.61 USD

According to Wall Street analysts, the average 1-year price target for CSTL is 36.61 USD with a low forecast of 30.3 USD and a high forecast of 43.05 USD.

What is Castle Biosciences Inc's Revenue forecast?
Projected CAGR
0%

For the last 6 years the compound annual growth rate for Castle Biosciences Inc's revenue is 56%. The projected CAGR for the next 3 years is 0%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.